Objective: To evaluate the impact of bifurcation characteristics on long-term clinical outcome after distal left main (LM) percutaneous coronary intervention (PCI) with a provisional side-branch (SB) stenting strategy. Background: Provisional SB stenting provides good results for patients with distal LM undergoing PCI. It is the preferred strategy in cases where a single ostium is involved (LAD or LCX). This strategy has never been specifically evaluated in more complex lesions involving the two side branches (medina 1.1.1). Methods: Methods: Individual data of patients with distal LM lesions included in the French Taxus, Friend, Lemax and large centers registries and treated with a provisional SB stenting strategy were analysed. Results: Results: A total of 454 patients were included, 199 (43.8%) with a 1.
Background: Previous trials indicated that radial access was superior to conventional femoral access for percutaneous coronary intervention in reducing bleeding and vascular complications in patients with acute coronary syndrome (ACS). However, the overall safety and efficacy of transradial coronary intervention (TRI) with drug eluting stent (DES) versus coronary artery bypass grafting (CABG) for patients with unprotected left main disease (UPLM) presenting with ACS is unknown. Methods: All consecutive patients with ACS undergoing TRI with DES (nϭ231) or CABG (nϭ357) for UPLM lesions in our center, between March 2008 and December 2010, were included. And a propensity-score matching was performed to adjust for differences in baseline clinical and angiographic characteristics between the two cohorts, yielding 154 pairs of matched patients. Results: Median clinical follow-up duration was 26 months. Patients undergoing CABG had higher unadjusted rates of all cause mortality, stroke, and myocardial infarction (MI). After propensity-score adjustment, baseline comorbidities and angiographic characteristics were similar between two groups. And no significant difference was observed between TRI and CABG group in all cause mortality (4.5% vs. 6.5%; P ϭ 0.454) and MI (5.2% vs. 7.8%; P ϭ 0.355). However, there was a significant increase in the incidence of stroke in CABG group (0 vs. 2.6%; Pϭ0.044), while a significantly increased target vessel revascularization (TVR) rate (13.0% vs. 5.2%; P ϭ 0.017) was observed in TRI group. Composite outcome (death/MI/stroke) was comparable between the TRI and CABG groups (7.1% vs. 12.3%; P ϭ 0.124). And the overall major adverse cardiac and cerebral events including death/MI/stroke/TVR were more frequently developed in patients undergoing TRI (18.2% vs. 15.6%; P ϭ 0.543). These findings were still consistent after adjustment by SYNTAX score with or without propensity score, and propensity score alone in Cox regression analysis. Conclusions: TRI with DES on UPLM disease for ACS patients are comparable to CABG in composite safety outcomes including death/MI/stroke. However, CABG is still superior to percutaneous coronary intervention in TVR despite using DES.
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Background: The effectiveness of left main coronary artery (LMCA) percutaneous coronary intervention (PCI) is inferior to coronary artery bypass surgery (CABG), mostly due to the higher risk of repeat revascularization. The LMCA has typically been treated as a single entity in studies comparing PCI and CABG. However, interventionalists recognize that there are differences in the technical complexity of LMCA PCI depending upon the lesion's location. The influence of lesion location on outcomes is not clear.
Methods:
We performed a systematic review and meta-analysis of percutaneous drug-eluted stent (DES) implantation in ostial and trunk versus distal unprotected LMCA lesions. Our co-primary endpoints were the incidence of major adverse cardiac events (MACE) and target lesion/vessel revascularization (TLR/TVR). We included studies that enrolled Ն100 patients and had Ͼ6 months follow-up.
Results:
We identified 11 studies involving 4,236 patients. Mean duration of follow-up was 26 months (range 20-36). We adopted the random effect model when computing the combined hazard ratio (HR) (test for heterogeneity p Ͻ 0.001 .
Conclusions:
Patients with ostial and trunk LMCA lesions treated with DES have better outcomes than patients with distal lesions. Our findings may support unprotected non-distal LMCA stenting as a primary approach in selected patient subsets. 
